The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,774.50
Bid: 1,774.00
Ask: 1,774.50
Change: 0.00 (0.00%)
Spread: 0.50 (0.028%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 1,774.50
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

BROKER RATINGS: Citi resumes Melrose at Buy; Peel cuts Pets At Home

Thu, 29th Jul 2021 10:36

(Alliance News) - The following London-listed shares received analyst recommendations Thursday and Wednesday:

----------

FTSE 100

----------

CITIGROUP RAISES FLUTTER PRICE TARGET TO 11,700 (9,600) PENCE - 'SELL'

----------

MORGAN STANLEY RAISES VODAFONE PRICE TARGET TO 185 (180) PENCE - 'OVERWEIGHT'

----------

CITIGROUP RESUMES MELROSE INDUSTRIES WITH 'BUY' - TARGET 185 PENCE

----------

CITIGROUP RAISES CRODA INTERNATIONAL PRICE TARGET TO 9,500 (8,500) PENCE - 'BUY'

----------

LIBERUM RAISES CRODA INTERNATIONAL PRICE TARGET TO 9,200 (7,400) PENCE - 'BUY'

----------

MORGAN STANLEY RAISES CRODA INTERNATIONAL PRICE TARGET TO 8,800 (7,800) PENCE - 'OVERWEIGHT'

----------

JPMORGAN RAISES SMITHS GROUP PRICE TARGET TO 1,900 (1,800) PENCE - 'OVERWEIGHT'

----------

GOLDMAN SACHS CUTS RECKITT BENCKISER PRICE TARGET TO 6,000 (6,350) PENCE - 'NEUTRAL'

----------

DEUTSCHE BANK CUTS RECKITT BENCKISER PRICE TARGET TO 7,200 (8,000) PENCE - 'BUY'

----------

JEFFERIES CUTS RECKITT BENCKISER PRICE TARGET TO 5,700 (6,050) PENCE - 'HOLD'

----------

JPMORGAN RAISES BAT PRICE TARGET TO 3,400 (3,100) PENCE - 'NEUTRAL'

----------

BARCLAYS RAISES GLAXOSMITHKLINE PRICE TARGET TO 1,350 (1,300) PENCE - 'UNDERWEIGHT'

----------

BARCLAYS RAISES ITV PRICE TARGET TO 135 (130) PENCE - 'EQUAL WEIGHT'

----------

UBS RAISES ITV PRICE TARGET TO 145 (140) PENCE - 'BUY'

----------

BOFA RAISES ITV PRICE TARGET TO 105 (100) PENCE - 'UNDERPERFORM'

----------

HSBC RAISES UNITED UTILITIES PRICE TARGET TO 970 (910) PENCE - 'REDUCE'

----------

HSBC RAISES SEVERN TRENT PRICE TARGET TO 3,010 (2,780) PENCE - 'BUY'

----------

HSBC CUTS LONDON STOCK EXCHANGE PRICE TARGET TO 7,400 (7,500) PENCE - 'HOLD'

----------

JPMORGAN RAISES BARCLAYS PRICE TARGET TO 240 (230) PENCE - 'OVERWEIGHT'

----------

GOLDMAN RAISES BARCLAYS PRICE TARGET TO 280 (270) PENCE - 'BUY'

----------

BERENBERG RAISES BARCLAYS PRICE TARGET TO 230 (220) PENCE - 'BUY'

----------

DEUTSCHE BANK RAISES BARCLAYS PRICE TARGET TO 240 (230) PENCE - 'BUY'

----------

UBS RAISES BARCLAYS PRICE TARGET TO 220 (210) PENCE - 'BUY'

----------

CREDIT SUISSE RAISES ST JAMES'S PLACE TARGET TO 1,600 (1,300) PENCE - 'NEUTRAL'

----------

CREDIT SUISSE UPS ST JAMES'S PLACE PRICE TARGET TO 1600 (1300) PENCE - NEUTRAL

----------

MORGAN STANLEY RAISES ST JAMES'S PLACE TARGET TO 1642 (1560) PENCE - 'EQUAL-WEIGHT'

----------

JPMORGAN CUTS RIO TINTO PRICE TARGET TO 7,770 (8,250) PENCE - 'OVERWEIGHT'

----------

GOLDMAN RAISES RIO TINTO PRICE TARGET TO 6,910 (6,830) PENCE - 'NEUTRAL'

----------

UBS CUTS RIO TINTO PRICE TARGET TO 5,000 (5,100) PENCE - 'SELL'

----------

FTSE 250

----------

PEEL HUNT CUTS PETS AT HOME TO 'ADD' ('BUY') - TARGET 525 PENCE

----------

PEEL HUNT RAISES MITCHELLS & BUTLERS TO 'BUY' ('HOLD') - TARGET 335 PENCE

----------

RBC CUTS RHI MAGNESITA PRICE TARGET TO 4,750 (5,200) PENCE - 'OUTPERFORM'

----------

CITIGROUP CUTS RHI MAGNESITA PRICE TARGET TO 4,700 (4,900) PENCE - 'NEUTRAL'

----------

BERENBERG CUTS NATIONAL EXPRESS PRICE TARGET TO 340 (370) PENCE - 'BUY'

----------

JPMORGAN RESUMES FIRSTGROUP WITH 'NEUTRAL' - TARGET 94 PENCE

----------

HSBC CUTS WIZZ AIR TO 'REDUCE' (HOLD) - PRICE TARGET 4,100 (4,500) PENCE

----------

LIBERUM RAISES VIRGIN MONEY PRICE TARGET TO 260 (165) PENCE - 'BUY'

----------

CREDIT SUISSE RAISES MAN GROUP PRICE TARGET TO 230 (220) PENCE - 'OUTPERFORM'

----------

MORGAN STANLEY RAISES MAN GROUP PRICE TARGET TO 255 (245) PENCE - 'OVERWEIGHT'

----------

GOLDMAN RAISES MAN GROUP PRICE TARGET TO 220 (200) PENCE - 'NEUTRAL'

----------

BARCLAYS RAISES MAN GROUP PRICE TARGET TO 210 (170) PENCE - 'EQUAL WEIGHT'

----------

CREDIT SUISSE RAISES LANCASHIRE PRICE TARGET TO 858 (850) PENCE - 'OUTPERFORM'

----------

JEFFERIES RAISES PRIMARY HEALTH PROPERTIES PT TO 179 (172) PENCE - 'BUY'

----------

RBC RAISES GREENCOAT UK WIND PRICE TARGET TO 145 (140) PENCE - 'OUTPERFORM'

----------

JPMORGAN CUTS INCHCAPE PRICE TARGET TO 986 (1,021) PENCE - 'OVERWEIGHT'

----------

JPMORGAN RAISES ELEMENTIS PRICE TARGET TO 155 (145) PENCE - 'NEUTRAL'

----------

JPMORGAN RAISES VESUVIUS PRICE TARGET TO 589 (587) PENCE - 'NEUTRAL'

----------

JPMORGAN RAISES SPECTRIS PRICE TARGET TO 3,200 (2,900) PENCE - 'NEUTRAL'

----------

HSBC CUTS PENNON GROUP TO 'REDUCE' (HOLD)

----------

BARCLAYS RAISES VICTREX PRICE TARGET TO 2,150 (1,870) PENCE - 'EQUAL WEIGHT'

----------

BARCLAYS CUTS UDG HEALTHCARE TO 'EQUAL WEIGHT' (OW) - TARGET 1,080 (975) PENCE

----------

OTHER MAIN MARKET AND AIM

----------

PEEL HUNT RAISES DISCOVERIE PRICE TARGET TO 1,150 (860) PENCE - 'BUY'

----------

PEEL HUNT RAISES HEADLAM GROUP PRICE TARGET TO 670 (550) PENCE - 'BUY'

----------

LIBERUM RAISES VERTU MOTORS PRICE TARGET TO 90 (80) PENCE - 'BUY'

----------

Copyright 2021 Alliance News Limited. All Rights Reserved.

More News
Today 06:00

US, European nations consider vaccinating workers exposed to bird flu

CHICAGO/LONDON, May 27 (Reuters) - The United States and Europe are taking steps to acquire or manufacture H5N1 bird flu vaccines that could be used to protect at-risk poultry and dairy workers, veterinarians and lab technicians, government officials said, moves influenza experts say could curb the threat of a pandemic.

Read more
24 May 2024 15:19

London close: Stocks mixed after disappointing retail sales data

(Sharecast News) - London stocks closed with mixed results on Friday, influenced by earlier declines in the US and Asian markets, as investors reacted to a larger-than-expected drop in UK retail sales.

Read more
24 May 2024 08:55

LONDON MARKET OPEN: FTSE 100 falls; retail sales plunge in April

(Alliance News) - Stock prices in London opened lower on Friday, with sentiment hurt across the globe.

Read more
24 May 2024 08:36

TOP NEWS: GSK celebrates Illinois jury verdict in Valadez case

(Alliance News) - GSK PLC on Friday welcomed the jury verdict in the Valadez case in Illinois state court, which found in GSK's favour in the first Zantac case to go to trial.

Read more
24 May 2024 07:52

LONDON BRIEFING: UK retail sales fall amid wet April; Co-Op Bank deal

(Alliance News) - Stocks are called to open lower on Friday, following New York lower, as hopes of interest rate cuts have come into question.

Read more
24 May 2024 07:30

Jury rules in favour of GSK in Zantac trial

(Sharecast News) - A court in Illinois has ruled in favour of GSK in the first Zantac case to go to trial, the UK drugs giant confirmed on Friday.

Read more
23 May 2024 19:21

Zantac not a cause of woman’s cancer, jury says in first trial over drug

CHICAGO, May 23 (Reuters) - A jury in Chicago on Thursday rejected an Illinois woman’s claim that the now discontinued heartburn drug Zantac caused her colon cancer, in the first trial out of thousands of lawsuits making similar allegations.

Read more
22 May 2024 22:59

What to know about bird flu in dairy cows and the risk to humans

CHICAGO, May 22 (Reuters) -

Read more
21 May 2024 11:23

AstraZeneca aims for $80 bln in total revenue by 2030

Sees $80 bln in 2030 revenue by 2030

*

Read more
21 May 2024 08:49

GSK's depemokimab asthma treatment meets endpoints in latest trials

(Alliance News) - GSK PLC on Tuesday announced positive results from trials of depemokimab, an "ultra-long-acting biologic" that could simplify treatment options for patients with severe asthma.

Read more
21 May 2024 07:21

GSK reports promising results from asthma treatment trials

(Sharecast News) - GSK announced promising results from phase three clinical trials evaluating the efficacy and safety of depemokimab in treating severe asthma with type 2 inflammation on Tuesday.

Read more
20 May 2024 16:11

IN BRIEF: GSK executive buys GBP20,026 worth shares

GSK PLC - London-based pharmaceuticals firm - Senior Vice President, Global Communications & Chief Executive Office, Sally Jackson, buys 1,120 shares at 1,788 pence each. Worth total GBP20,026.

Read more
17 May 2024 17:38

London's FTSE nudges lower for week after record run

Haleon falls after GSK offloads remaining stake

*

Read more
17 May 2024 15:52

London close: Stocks recoup some earlier losses

(Sharecast News) - London stocks remained in negative territory by Friday's close, although they managed to recoup some of the losses seen earlier in the session as Wall Street opened with positive momentum.

Read more
17 May 2024 11:52

LONDON MARKET MIDDAY: FTSE 100 slides; Eurozone inflation steady

(Alliance News) - Stock prices in London were lacklustre at midday on Friday, as investors eye the trajectory of interest rates across the globe.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.